Summary: Reschedule Marijuana, Support Research,  Allow Veterans to Discuss Legal Use, Harmonize State and Federal Laws 

As a scientist, I support quality research and development of improved to treatment methods for patients. Therefore, I’m in favor of expanding research on medical marijuana.  Classification as schedule I has impeded clinical trials. Rescheduling will aid in research by expanding the sources of the marijuana studied, and easing the paperwork process for clinical trials. There have been anecdotal reports suggesting that it can alleviate ALS symptoms and help treat bipolar disorder. Cannabidiol may inhibit the proliferation of breast cancer cells. In a double-blind, placebo-controlled phase II clinical trial in Barcelona, cannabis-based medicine was well tolerated and provided protection against delayed chemotherapy induced nausea and vomiting.  Research must be built on preliminary work done on a number of conditions including Huntington’s Disease, Multiple Sclerosis, PTSD, and Parkinson’s.

Additionally, I aim to remove the federal restrictions that currently prohibit the Department of Veterans Affairs from discussing State medical marijuana options with veterans.

States have come to rely on income generated from the sale of marijuana and have generated around $559 million from cannabis taxes in 2017. Currently 29 States and DC have medical marijuana laws that permit use within the State.  Eight States allow recreational use. State and Federal law needs to be harmonized so States can continue to regulate as they best see fit. Businesses operating within the legal requirements set by the State should be able to continue to operate without fear of Federal prosecution, and Federal asset forfeiture.  Businesses who grow and dispense marijuana need the security offered by using credit cards and FDIC insured banks, which they currently are not allowed to do.  They are also are prohibited from deducting business expenses. That is just wrong.